Photanol is a Circular Carbon Chemicals production platform company that is at the forefront of a biotech revolution. They have developed a groundbreaking technology that utilizes proprietary engineered cyanobacteria to transform carbon dioxide (CO2) and sunlight into valuable chemicals. With the aim of restoring balance on the planet, Photanol's innovative process enables them to create any carbon chemical, while also actively absorbing CO2.

Since their formation in 2008, Photanol has achieved significant milestones. They secured their first patent in 2008, proving that cyanobacteria can synthesize ethanol, and have since enhanced this technology to produce essential industrial compounds. Photanol's dedication to circular chemistry has led to strategic partnerships with industry leaders such as Corbion and Nouryon, enabling them to develop renewable lactic acid and glycolic acid directly from CO2.

In 2020, Photanol opened their first Industrial Pilot Plant, showcasing the scalability of their technology. They have also partnered with Renolit to bring circular innovation to the healthcare industry. With plans to scale up to a commercial plant by 2027 and commence commercial production in 2028, Photanol is well on its way to revolutionizing the sustainable production of chemicals.

By harnessing the power of cyanobacteria, Photanol offers a paradigm shift for a sustainable future. Their platform technology can create virtually any carbon compound, transforming industries towards circularity while minimizing land and water usage. Photanol's mission is to restore balance to the planet, all while powering the world